984
Views
12
CrossRef citations to date
0
Altmetric
Research Article

Mechanistic studies on human N-acetylgalactosamine kinase

&
Pages 370-376 | Received 06 Apr 2009, Accepted 27 May 2009, Published online: 29 Oct 2009
 

Abstract

N-Acetylgalactosamine kinase (GALK2) is a small molecule kinase from the GHMP family which phosphorylates N-acetylgalactosamine at the expense of ATP. Recombinant GALK2 expressed in, and purified from, Escherichia coli was shown to be active with the following kinetic parameters: Michaelis constant for ATP, 14 ± 3 μM; Michaelis constant for N-acetylgalactosamine, 40 ± 14 μM; and turnover number, 1.0 ± 0.1 s−1. The combination of substrate inhibition by N-acetylgalactosamine and α-methylgalactopyranoside acting as an uncompetitive inhibitor with respect to ATP suggested that the enzyme has an ordered ternary complex mechanism in which ATP is the first substrate to bind. The effects of pH on the kinetic parameters provided evidence for ionizable residues playing a role in substrate binding and catalysis. These results are discussed in the context of the mechanisms of the GHMP kinases.

Acknowledgements

We thank Peter McColgin and Andrew Frazer who carried out preliminary work on human GALK2 and Prof Hazel Holden (University of Wisconsin) who provided the GALK2 expression construct.

Declaration of interest: This work was funded in part by a grant from the Royal Society, UK (2004/R1).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.